Assessment of platelet activation and phagocytic activity in gastric cancer patients

Table 2 Mean values of platelet counts, levels of soluble platelet-selectin and interleukin-6 in cancer patients-early carcinoma-E advanced carcinoma with lymph node involvement-A, metastatic cancer-M and in control group (mean ± SD)

	PLT	sP-selectin	IL-6
Study group E1	247.33 ± 42.92	67.93 ± 74.49	20.68 ± 6.31
	E1 vs C	E1 vs C	E1 vs C
	0.8 < P < 0.9	P < 0.05	P < 0.01
Study group E2	662.83 ± 335.23	153.37 ± 174.59	10.90 ± 8.43
	E1 vs E2	E1 vs E2	E1 vs E2
	P < 0.05	0.5 < P < 0.6	0.1 < P < 0.2
	E2 vs C	E2 vs C	E2 vs C
	P < 0.05	0.6 < P < 0.7	0.05 < P < 0.1
Study group A1	344.28 ± 266.40	193.23 ± 143.70	11.51 ± 8.44
	A1 vs C	A1 vs C	A1 vs C
	0.05 < P < 0.1	0.05 < P < 0.1	P < 0.001
Study group A2	584.25 ± 237.54	278.54 ± 158.64	20.42 ± 12.88
	A1 vs A2	A1 vs A2	A1 vs A2
	P < 0.05	P < 0.001	0.2 < P < 0.3
	A2 vs C	A2 vs C	A2 vs C
	P < 0.01	0.2 < P < 0.3	P < 0.05
Study group M1	335.84 ± 154.08	173.71 ± 116.79	8.44 ± 5.63
	M1 vs C	M1 vs C	M1 vs C
	P < 0.01	0.1 < P < 0.2	P < 0.001
Study group M2	451.55 ± 210.74	178.96 ± 84.56	15.26 ± 12.73
	M1 vs M2	M1 vs M2	M1 vs M2
	0.2 < P < 0.3	0.1 < P < 0.2	0.1 < P < 0.2
	M2 vs C	M2 vs C	M2 vs C
	P < 0.01	0.5 < P < 0.6	P < 0.05
Control group C	247.78 ± 44.74	130.38 ± 48.35	2.45 ± 1.44

PLT: Platelet count; sP-selectin: Soluble platelet selectin; IL: Interleukin.